US 10894797
Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors
granted A61KA61K31/5383A61P
Quick answer
US patent 10894797 (Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors) held by NIKANG THERAPEUTICS, INC. expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NIKANG THERAPEUTICS, INC.
- Grant date
- Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/5383, A61P, A61P35/00